EMD-29605

Single-particle
2.88 Å
EMD-29605 Deposition: 27/01/2023
Map released: 11/10/2023
Last modified: 03/01/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links

EMD-29605

TpeA bound closed MthK-A88F mutant in nanodisc

EMD-29605

Single-particle
2.88 Å
EMD-29605 Deposition: 27/01/2023
Map released: 11/10/2023
Last modified: 03/01/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Sample Organism: Methanothermobacter thermautotrophicus
Sample: TpeA bound MthK A88F mutant in 0 Ca2+
Fitted models: 8fz7 (Avg. Q-score: 0.511)

Deposition Authors: Agarwal S, Nimigean CM
Calcium-gated potassium channel blockade via membrane-facing fenestrations.
Fan C, Flood E , Sukomon N , Agarwal S, Allen TW , Nimigean CM
(2024) Nat Chem Biol , 20 , 52 - 61
PUBMED: 37653172
DOI: doi:10.1038/s41589-023-01406-2
ISSN: 1552-4469
Abstract:
Quaternary ammonium blockers were previously shown to bind in the pore to block both open and closed conformations of large-conductance calcium-activated potassium (BK and MthK) channels. Because blocker entry was assumed through the intracellular entryway (bundle crossing), closed-pore access suggested that the gate was not at the bundle crossing. Structures of closed MthK, a Methanobacterium thermoautotrophicum homolog of BK channels, revealed a tightly constricted intracellular gate, leading us to investigate the membrane-facing fenestrations as alternative pathways for blocker access directly from the membrane. Atomistic free energy simulations showed that intracellular blockers indeed access the pore through the fenestrations, and a mutant channel with narrower fenestrations displayed no closed-state TPeA block at concentrations that blocked the wild-type channel. Apo BK channels display similar fenestrations, suggesting that blockers may use them as access paths into closed channels. Thus, membrane fenestrations represent a non-canonical pathway for selective targeting of specific channel conformations, opening novel ways to selectively drug BK channels.